Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Hanenberg

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Frontiers in Immunology|June 29, 2018
Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface SignaturesOscar P B Wiklander, R Beklem Bostancioglu, Joshua A Welsh, et al.
Haematologica|March 4, 2014
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-HematologyDaniela De Rocco, Roberta Bottega, Enrico Cappelli, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Journal of Medical Genetics|November 16, 2006
A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research NetworkJosé Antonio Casado, Elsa Callén, Ariana Jacome, et al.
Molecular Cancer Therapeutics|October 24, 2015
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic ModelEva Tonsing-Carter, Barbara J Bailey, M Reza Saadatzadeh, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Molecular Cancer Therapeutics|February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsCarolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Frontiers in Immunology|June 29, 2018
Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface SignaturesOscar P B Wiklander, R Beklem Bostancioglu, Joshua A Welsh, et al.
Haematologica|March 4, 2014
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-HematologyDaniela De Rocco, Roberta Bottega, Enrico Cappelli, et al.
Journal for Immunotherapy of Cancer|April 7, 2023
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Journal of Medical Genetics|November 16, 2006
A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research NetworkJosé Antonio Casado, Elsa Callén, Ariana Jacome, et al.
Molecular Cancer Therapeutics|October 24, 2015
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic ModelEva Tonsing-Carter, Barbara J Bailey, M Reza Saadatzadeh, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Pageof 16